Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)

Christian F. Singer, Georg Pfeiler, Michael Hubalek, Rupert Bartsch, Herbert Stöger, Angelika Pichler, Edgar Petru, Vesna Bjelic‐Radisic, Richard Greil, Margaretha Rudas, Muy‐Kheng M. Tea, Viktor Wette, Andreas Petzer, P. Sevelda, Daniel Egle, Peter Dubsky, Martin Filipits, Florian Fitzal, Ruth Exner, R. Jakesz, Marija Balić, Christoph Tinchon, Zsuzsanna Bagó-Horváth, Sophie Frantal, Michael Gnant